SearchDictionaryMobileLogin

Oxygen

40707  relevant articles (1685 outcomes, 3830 trials/studies) found for this Bio-Agent

Description: An element with atomic symbol O, atomic number 8, and atomic weight 16. It is the most abundant element on earth and essential for respiration.

Also Known As:
Dioxygen

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Zhang, John H: 15 articles (09/2008 - 02/2002)
2. Yildiz, Senol: 14 articles (08/2008 - 06/2003)
3. Intaglietta, Marcos: 12 articles (10/2008 - 10/2003)
4. Cabrales, Pedro: 10 articles (10/2008 - 10/2003)
5. Bennett, M: 10 articles (03/2007 - 01/2001)
6. Tsai, Amy G: 9 articles (10/2008 - 10/2003)
7. Dewhirst, Mark W: 9 articles (01/2008 - 04/2002)
8. Giaccia, Amato J: 8 articles (12/2007 - 01/2003)
9. Hampson, Neil B: 7 articles (09/2008 - 06/2003)
10. Freilich, Daniel: 7 articles (06/2008 - 10/2004)

Related Diseases

1. Anoxia (Hypoxia)
11/01/2009 - "We found that (1) in contrast to oxygen partial pressure in blood (P(a)O(2)), the baseline value of P(t)O(2) in summer euthermic AGS is significantly higher than in rats; (2) both P(t)O(2) and P(a)O(2) are dramatically reduced by inspired 8% O(2) in AGS and rats, but AGS have a greater capacity in P(t)O(2) to cope with environmental hypoxia; (3) metabolic rate before, during, and after hypoxic exposure is consistently lower in AGS than in rats; (4) the respiratory responding patterns to hypoxia in the two species differ in that f(R) decreases in AGS but increases in rats. "
09/13/2004 - "Acute hypoxia reduced the median oxygen partial pressure (pO(2)) dramatically (1 vs 10 mmHg in controls), whereas in chronically hypoxic tumours the pO(2) was significantly improved (median pO(2)=4 mmHg), however not reaching the control level. "
07/04/1977 - "Portacaval transposition and end-to-side shunt led to a striking oxygen deficit of the liver tissue with no incidence of compensation by the hepatic artery; Oxygen supply was improved considerably by a side-to-side shunt and tissue hypoxia could be prevented by a mesenterico-caval shunt and splenocaval shunt. "
01/01/1995 - "Measurement of cardiac output and clinical assessment of the patients' oxygen requirements will complete the macro picture of supply and demand and although computed indicators of hypoxia have been improved in recent years (1, 2) the definitive diagnosis of histohypoxia requires the measurement of the cellular and subcellular products of metabolic processes that are present when an inappropriate concentration of oxygen has been experienced. "
09/24/1983 - "That the fall in oxygen saturation was significantly greater (p less than 0.05) in the obese non-responders suggests that central as well as mechanical factors may be important for the genesis of nocturnal hypoxia and is evidence for a disturbance of central nervous function in some obese women."
Order ALL the reference details at left...
2. Chronic Obstructive Pulmonary Disease (COPD)
3. Neoplasms (Cancer)
05/01/1992 - "Krogh cylinder models, which incorporate these data for perivascular oxygen tension, along with morphometric data obtained from the same tumor model suggest that hypoxic regions will exist between tumor vessels in the tumor center unless O2 consumption rates are well below 0.6 ml/100 g/min. The low perivascular measurements observed near the tumor center combined with the theoretical considerations suggest, for this model at least, that tissue oxygenation may best be improved by increasing red cell velocity and input pO2 and reducing oxygen consumption. "
03/15/2007 - "Although the tumors did not respond to oxygen inhalation, each tumor had a different pO(2), and there was a clear trend between level of oxygenation at time of irradiation and tumor growth delay, with considerably better outcome when mean pO(2) > 10 mm Hg. The comparatively small baseline hypoxic fraction in the group of small tumors was virtually eliminated by breathing oxygen, and the growth rate was significantly reduced for tumors on rats breathing oxygen during irradiation. "
03/15/2007 - "RESULTS: Large tumors (>3.0 cm(3)) exhibited significantly greater hypoxic fractions and lower mean partial pressure of oxygen (pO(2)) than their smaller counterparts (<1.5 cm(3)). "
07/01/2000 - "Polysomnography performed before and after total tumor resection showed significant improvement in nocturnal respiratory rate, respiratory disturbance index, and oxygen desaturation. "
03/01/1993 - "Administration of the NNK and exposure of the animals to an atmosphere of 65% oxygen resulted in a statistically significant reduction in tumor size but did not alter the histological tumor type or tumor incidence when compared with carcinogen treated animals maintained under ambient air. "
Order ALL the reference details at left...
4. Ischemia
5. Apnea

Related Drugs and Biologics

1. Free Radicals
2. Hemoglobins (Hemoglobin)
3. Glucose (Dextrose)
4. Lactic Acid
5. Carbon Monoxide
6. Nitrous Oxide (Laughing Gas)
7. Carbon Dioxide
8. Superoxide Dismutase
9. Nitrogen
10. Enzymes

Related Therapies and Procedures

1. Resuscitation
2. Mechanical Ventilators (Ventilator)
3. Drug Therapy (Chemotherapy)
4. Artificial Respiration (Mechanical Ventilation)
5. Aftercare (After-Treatment)

Best Treatments:
Research Summary Report
on Anoxia

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 1349 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>